Selective early medical treatment of the patent ductus arteriosus in extremely low gestational age infants: a pilot randomised controlled trial (SMART-PDA)

Overview of attention for article published in Archives of Disease in Childhood -- Fetal & Neonatal Edition, May 2026

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

blogs: 1 blog
twitter: 15 X users
facebook: 1 Facebook page

video: 1 YouTube creator
bluesky: 1 Bluesky user
podcasts: 1 podcast

Readers on

mendeley: 6 Mendeley

So far, Altmetric has seen 15 X posts from 15 X users, with an upper bound of 40,427 followers.

RT @NeonatologyJC: #126 Just read the SMART-PDA pilot RCT by @souvik_neo (Mitra et al) in @ADC_BMJ Neonatal. First trial to exclusively…

#126 Just read the SMART-PDA pilot RCT by @souvik_neo (Mitra et al) in @ADC_BMJ Neonatal. First trial to exclusively enroll infants under 26 weeks GA for selective early PDA treatment. #NeonatalMedicine #PDA #JournalClub https://t.co/OPWhlpBG5Q

Early echocardiography screening and selective pharmacotherapy using the SMART-PDA (selective medical treatment - patent ductus arteriosus) algorithm may enhance the probability of survival with less morbidities in infants born <26 weeks. Read more …

RT @EBNEO: Mitra et al. conducted a multicentre pilot RCT to assess feasibility of recruitment and compare clinical outcomes in a trial of…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 11 additional X posts.